← All diseases
Cancer
Bile duct cancer
Would you like to receive a message when there is new research on cholangiocarcinoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a one-sentence summary explaining what was studied appears above each publication — and you'll be notified as soon as new research on Cholangiocarcinoma is published. View what Premium costs.
Publications and studies (2071)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in liver transplantation for cancer: The future of transplant oncology. (2019/07/30) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review. (2019/07/23) ♡
- Anti-inflammatory effect of naringin and sericin combination on human peripheral blood mononuclear cells (hPBMCs) from patient with psoriasis. (2019/07/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunobiology of cholangiocarcinoma. (2019/07/10) ♡
- Impact of peroral cholangioscopy on the management of indeterminate biliary conditions: a multicentre prospective trial. (2019/07/01) ♡
- Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency. (2019/07/01) ♡
- Lnc-LFAR1 affects intrahepatic cholangiocarcinoma proliferation, invasion, and EMT by regulating the TGFβ/Smad signaling pathway. (2019/07/01) ♡
- LncRNA-SNHG3 is an independent prognostic biomarker of intrahepatic cholangiocarcinoma. (2019/07/01) ♡
- Laser ablation in biliary tree: analysis of the intraductal and superficial thermal effects during the treatment. (2019/07/01) ♡
- Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma. (2019/06/04) ♡
- A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance. (2019/06/01) ♡
- MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma. (2019/06/01) ♡
- Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers. (2019/06/01) ♡
- [Primary malignant hepatic tumors other than hepatocarcinoma or cholangiocarcinoma. A series of cases]. (2019/06/01) ♡
- How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI? (2019/05/01) ♡
- Focal liver lesions following Fontan palliation of single ventricle physiology: A radiology-pathology case series. (2019/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance. (2019/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The tumour microenvironment and immune milieu of cholangiocarcinoma. (2019/05/01) ♡
- Clinical Usefulness of Perioperative C-reactive Protein/Albumin Ratio in Patients With Intrahepatic Cholangiocarcinoma: A Retrospective Single Institutional Study. (2019/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Choledochal Cyst and Malignancy: A Plea for Lifelong Follow-Up. (2019/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI. (2019/04/01) ♡
- Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. (2019/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progress in diagnosis and surgical treatment of perihilar cholangiocarcinoma. (2019/04/01) ♡
- Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma. (2019/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary hepatic tuberculosis masquerading as intrahepatic cholangiocarcinoma. (2019/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Combined Hepatocellular-Cholangiocarcinoma in a Patient With Cirrhosis Due to Cholesteryl Ester Storage Disease. (2019/04/01) ♡
- Implementation of comprehensive rehabilitation therapy in postoperative care of patients with cholangiocarcinoma and its impact on patients' quality of life. (2019/04/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma. (2019/03/15) ♡
- Analysis of Local Control and Pain Control After Spine Stereotactic Radiosurgery Reveals Inferior Outcomes for Hepatocellular Carcinoma Compared With Other Radioresistant Histologies. (2019/03/01) ♡
- Comparison of stool examination techniques to detect Opisthorchis viverrini in low intensity infection. (2019/03/01) ♡
- Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis. (2019/03/01) ♡
- Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012. (2019/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. How to do laparoscopic associating liver partition with portal vein ligation for staged hepatectomy. (2019/03/01) ♡
- Mitochondrial division inhibitor-1 potentiates cisplatin-induced apoptosis via the mitochondrial death pathway in cholangiocarcinoma cells. (2019/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions. (2019/03/01) ♡
- Diagnosis by 64-Row Multidetector Computed Tomography for Longitudinal Superficial Extension of Distal Cholangiocarcinoma. (2019/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Regional therapies for the treatment of primary and metastatic hepatic tumors: A disease-based review of techniques and critical appraisal of current evidence. (2019/03/01) ♡
- Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. (2019/03/01) ♡
- Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma. (2019/03/01) ♡
- Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma. (2019/03/01) ♡
- Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience. (2019/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment. (2019/02/11) ♡
- Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. (2019/02/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Noncoding RNA in Cholangiocarcinoma. (2019/02/01) ♡
- Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma. (2019/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Update on the pathology of liver neoplasms. (2019/02/01) ♡
- KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study. (2019/02/01) ♡
- An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer. (2019/02/01) ♡
- Neoadjuvant chemoradiotherapy followed by liver transplantation is a promising treatment for patients with unresectable hilar cholangiocarcinoma: A case report. (2019/02/01) ♡
- Palliative endoscopic drainage of malignant stenosis of biliary confluence: Efficiency of multiple drainage approach to drain a maximum of liver segments. (2019/02/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.